2014 Chrysler Town & Country Touring on 2040-cars
8536 Colerain Ave, Cincinnati, Ohio, United States
Engine:3.6L V6 24V MPFI DOHC
Transmission:Automatic
VIN (Vehicle Identification Number): 2C4RC1BG6ER409034
Stock Num: 93658
Make: Chrysler
Model: Town & Country Touring
Year: 2014
Exterior Color: True Blue Pearlcoat
Interior Color: Dark Frost Beige / Medium Frost Bei
Options: Drive Type: FWD
Number of Doors: 4 Doors
Mileage: 6
Up to $10,000 off our in stock 2014 Inventory! We will beat any deal you have in writing on the same vehicle from any dealer. Just write up your Northgate deal and ask for the manager. In todays automotive marketplace, there are many fine automobiles to choose from and many excellent dealers eager for your business. Your purchase experience with Northgate will be pleasant and you will be satisfied with your Chrysler, Dodge, Jeep, Ram, Certified or Pre-owned vehicle. Our team of professionals stand ready to ensure that your experience is a joy. All vehicles are plus tax and fees. Some vehicles have extra rebates only if you finance through Northgate. Ask associate for details. Best Prices! Best Service! Best Location!
Chrysler Town & Country for Sale
2012 chrysler town & country touring(US $26,750.00)
2014 chrysler town & country touring-l(US $30,800.00)
2014 chrysler town & country touring-l(US $33,000.00)
2011 chrysler town & country limited(US $19,900.00)
2014 chrysler town & country touring(US $24,900.00)
2014 chrysler town & country touring(US $25,900.00)
Auto Services in Ohio
Xenia Radiator & Auto Service ★★★★★
West Main Auto Repair ★★★★★
Top Knotch Automotive ★★★★★
Tom Hatem Automotive ★★★★★
Stanford Allen Chevrolet Cadillac ★★★★★
Soft Touch Car Wash Systems ★★★★★
Auto blog
More 2015 Chrysler 200 photos surface
Wed, 08 Jan 2014Just 24 hours after the first official 2015 Chrysler 200 shot made its way onto the web, a whole smattering of images have surfaced, courtesy of the folks at Motorward. Here, we can see the new Chrysler family sedan from every angle, including the interior, and might we say, she's pretty.
As we told you yesterday, the new 200 will be offered with either a 2.4-liter four-cylinder engine with 184 horsepower and 173 pound-feet of torque or a 3.6-liter Pentastar V6 with 295 hp and 262 lb-ft. A nine-speed automatic transmission accessed through Chrysler's rotary shifter (mounted on a Volvo-style floating center console) will direct power to the wheels. We've heard that both front- and all-wheel drive will be available, and what's more, it's been said that the new 200 will be able to achieve at least 35 miles per gallon on the highway.
An on-sale date has yet to be announced, but the new 200 will reportedly be priced at $21,700, not including $995 for destination. Have a look at the new round of photos in the gallery above - the striking blue model above looks to be the sportier 200S - and stay tuned for the officially official stuff early next week... if not sooner.
2017 North American Car, Truck, and Utility Vehicle of the Year finalists revealed
Tue, Nov 15 2016The finalists for the 2017 North American Car, Truck, and Utility Vehicle of the Year were announced Tuesday at AutoMobility LA ahead of the 2016 LA Auto Show. Approximately 60 judges, including Autoblog's editor-in-chief Mike Austin, evaluated over 40 vehicles and named three models as the finalists in each category. The award for the Utility Vehicle of the Year is new for 2017 and separates SUVs, crossovers, and minivans from pickup trucks. The finalists are: Car of the Year: Chevrolet Bolt Genesis G90 Volvo S90 Truck of the Year: Ford F-Series Super Duty Honda Ridgeline Nissan Titan Utility Vehicle of the Year Chrysler Pacifica Jaguar F-Pace Mazda CX-9 The winners for the 24th annual NACTOY awards will be named on January 9 at the Detroit Auto Show. Related Video: Chevrolet Chrysler Ford Honda Jaguar Mazda Nissan Truck Crossover Minivan/Van SUV Electric Luxury Sedan north american car of the year NACTOY
Fiat Chrysler says it did not know about Marchionne's illness
Fri, Jul 27 2018ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.




